New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules (Q30983806)

28 June 2017

1 reference

title

New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules (English)

1 reference

28 June 2017

1 reference

El Kasmi KC

1

1 reference

PubMed ID

11257340

28 June 2017

Muller CP

series ordinal

2

1 reference

PubMed ID

11257340

28 June 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

28 June 2017

1 reference

28 June 2017

19

1 reference

28 June 2017

17-19

1 reference

28 June 2017

2238-2244

1 reference

Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Implications of the human immunodeficiency virus epidemic for control and eradication of measles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Recombinant bacille Calmette-Guérin priming against measles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Recombinant bacille Calmette-Guérin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Differences in the Appearance of Antibodies to Structural Components of Measles Virus after Immunization with Inactivated and Live Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Mapping amino acids of the measles virus hemagglutinin responsible for receptor (CD46) downregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Enhanced antigenicity of a four-contact-residue epitope of the measles virus hemagglutinin protein by phage display libraries: evidence of a helical structure in the putative active site

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900452-7

7 January 2021

10.1016/S0264-410X(00)00452-7

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

11257340